Cigna is one of the major players in the health insurance market, with almost 40 years in the business. The company ranked ...

Biosimilar adoption remains a key growth driver, with plans to expand offerings in 2025. While analysts raised concerns about cost pressures and competitive dynamics, Cigna remains focused on ...

We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take ...

Cigna is a coverage provider that offers Medicare supplemental insurance and Medicare Advantage plans for adults over 65. Its website has a quote tool to help you estimate your rates, and many of ...

Cigna is positioned to benefit from utilization normalization and aims for 10%-14% annual EPS growth. See why I rate CI stock a buy at current prices.